Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Datamonitor
Datamonitor
Activities:
Media
Finance
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Media
Sales of generic HIV drugs to double by 2019
Patent expiries will halve existing HIV drug sales, says Datamonitor
Media
FDA approves therapy for prostate cancer
Manufactured by Seattle-based Dendreon
Media
US Health Bill a ‘double-edged sword’ for pharma sector
Mixed outlook for pharma industry but rising revenues expected from 2015 as volumes increase
Regulatory
Pulling back from the brink
The US healthcare reform bill raises as many questions as it answers for Big Pharma
Drug Delivery
Ondansetron RapidFilm gains European approval
Suitable for children and adults with swallowing difficulties
Media
Diabetes market to see rapid growth, says Datamonitor
But one of the main growth drivers of type 2 diabetes drugs will not be addressed on a large scale.
Media
Big Pharma CVD sales under threat from generics
Pharmaceutical companies will struggle to profit from the CVD market over the next 10 years.
Subscribe now